Global GI tract (Upper and Lower) Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread) | Decision Market Reports

Home < Healthcare & Medical Devices < Global GI tract (Upper and Lower) Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Global GI tract (Upper and Lower) Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Request Methodolgy Request Sample Request Customization

The GI tract (Upper and Lower) market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global GI tract (Upper and Lower) market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global GI tract (Upper and Lower) market. The report focuses on well-known providers in the global GI tract (Upper and Lower) industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the GI tract (Upper and Lower) Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global GI tract (Upper and Lower) market covered in Chapter 4:
Abbott Laboratories
Allergan PLC
Pfizer Inc.
GlaxoSmithKline PLC
AbbVie Inc.
AstraZeneca
Astellas Pharma Inc.
Janssen Pharmaceuticals Inc. (Johnson & Johnson)
Bayer AG

In Chapter 11 and 13.3, on the basis of types, the GI tract (Upper and Lower) market from 2015 to 2026 is primarily split into:
Antacids
Laxatives
Antidiarrheal agents
Antiemetics
Antiulcer agents
Other Drug Types

In Chapter 12 and 13.4, on the basis of applications, the GI tract (Upper and Lower) market from 2015 to 2026 covers:
Inflammatory Ulcerative Colitis
Cyclic vomiting syndrome (CVS)
Dyspepsia
Dysphagia
Gastroesophageal reflux disease (GERD)
Irritable Bowel Syndrome
Crohn's Disease
Celiac Disease
Gastroenteritis
Other Applications

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global GI tract (Upper and Lower) Market Share by Type (2020-2026)
1.5.2 Antacids
1.5.3 Laxatives
1.5.4 Antidiarrheal agents
1.5.5 Antiemetics
1.5.6 Antiulcer agents
1.5.7 Other Drug Types
1.6 Market by Application
1.6.1 Global GI tract (Upper and Lower) Market Share by Application (2020-2026)
1.6.2 Inflammatory Ulcerative Colitis
1.6.3 Cyclic vomiting syndrome (CVS)
1.6.4 Dyspepsia
1.6.5 Dysphagia
1.6.6 Gastroesophageal reflux disease (GERD)
1.6.7 Irritable Bowel Syndrome
1.6.8 Crohn's Disease
1.6.9 Celiac Disease
1.6.10 Gastroenteritis
1.6.11 Other Applications
1.7 GI tract (Upper and Lower) Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on GI tract (Upper and Lower) Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter's Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of GI tract (Upper and Lower) Market
3.1 Value Chain Status
3.2 GI tract (Upper and Lower) Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of GI tract (Upper and Lower)
3.2.3 Labor Cost of GI tract (Upper and Lower)
3.2.3.1 Labor Cost of GI tract (Upper and Lower) Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 Abbott Laboratories
4.1.1 Abbott Laboratories Basic Information
4.1.2 GI tract (Upper and Lower) Product Profiles, Application and Specification
4.1.3 Abbott Laboratories GI tract (Upper and Lower) Market Performance (2015-2020)
4.1.4 Abbott Laboratories Business Overview
4.2 Allergan PLC
4.2.1 Allergan PLC Basic Information
4.2.2 GI tract (Upper and Lower) Product Profiles, Application and Specification
4.2.3 Allergan PLC GI tract (Upper and Lower) Market Performance (2015-2020)
4.2.4 Allergan PLC Business Overview
4.3 Pfizer Inc.
4.3.1 Pfizer Inc. Basic Information
4.3.2 GI tract (Upper and Lower) Product Profiles, Application and Specification
4.3.3 Pfizer Inc. GI tract (Upper and Lower) Market Performance (2015-2020)
4.3.4 Pfizer Inc. Business Overview
4.4 GlaxoSmithKline PLC
4.4.1 GlaxoSmithKline PLC Basic Information
4.4.2 GI tract (Upper and Lower) Product Profiles, Application and Specification
4.4.3 GlaxoSmithKline PLC GI tract (Upper and Lower) Market Performance (2015-2020)
4.4.4 GlaxoSmithKline PLC Business Overview
4.5 AbbVie Inc.
4.5.1 AbbVie Inc. Basic Information
4.5.2 GI tract (Upper and Lower) Product Profiles, Application and Specification
4.5.3 AbbVie Inc. GI tract (Upper and Lower) Market Performance (2015-2020)
4.5.4 AbbVie Inc. Business Overview
4.6 AstraZeneca
4.6.1 AstraZeneca Basic Information
4.6.2 GI tract (Upper and Lower) Product Profiles, Application and Specification
4.6.3 AstraZeneca GI tract (Upper and Lower) Market Performance (2015-2020)
4.6.4 AstraZeneca Business Overview
4.7 Astellas Pharma Inc.
4.7.1 Astellas Pharma Inc. Basic Information
4.7.2 GI tract (Upper and Lower) Product Profiles, Application and Specification
4.7.3 Astellas Pharma Inc. GI tract (Upper and Lower) Market Performance (2015-2020)
4.7.4 Astellas Pharma Inc. Business Overview
4.8 Janssen Pharmaceuticals Inc. (Johnson & Johnson)
4.8.1 Janssen Pharmaceuticals Inc. (Johnson & Johnson) Basic Information
4.8.2 GI tract (Upper and Lower) Product Profiles, Application and Specification
4.8.3 Janssen Pharmaceuticals Inc. (Johnson & Johnson) GI tract (Upper and Lower) Market Performance (2015-2020)
4.8.4 Janssen Pharmaceuticals Inc. (Johnson & Johnson) Business Overview
4.9 Bayer AG
4.9.1 Bayer AG Basic Information
4.9.2 GI tract (Upper and Lower) Product Profiles, Application and Specification
4.9.3 Bayer AG GI tract (Upper and Lower) Market Performance (2015-2020)
4.9.4 Bayer AG Business Overview

5 Global GI tract (Upper and Lower) Market Analysis by Regions
5.1 Global GI tract (Upper and Lower) Sales, Revenue and Market Share by Regions
5.1.1 Global GI tract (Upper and Lower) Sales by Regions (2015-2020)
5.1.2 Global GI tract (Upper and Lower) Revenue by Regions (2015-2020)
5.2 North America GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
5.3 Europe GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
5.6 South America GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)

6 North America GI tract (Upper and Lower) Market Analysis by Countries
6.1 North America GI tract (Upper and Lower) Sales, Revenue and Market Share by Countries
6.1.1 North America GI tract (Upper and Lower) Sales by Countries (2015-2020)
6.1.2 North America GI tract (Upper and Lower) Revenue by Countries (2015-2020)
6.1.3 North America GI tract (Upper and Lower) Market Under COVID-19
6.2 United States GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
6.2.1 United States GI tract (Upper and Lower) Market Under COVID-19
6.3 Canada GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
6.4 Mexico GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)

7 Europe GI tract (Upper and Lower) Market Analysis by Countries
7.1 Europe GI tract (Upper and Lower) Sales, Revenue and Market Share by Countries
7.1.1 Europe GI tract (Upper and Lower) Sales by Countries (2015-2020)
7.1.2 Europe GI tract (Upper and Lower) Revenue by Countries (2015-2020)
7.1.3 Europe GI tract (Upper and Lower) Market Under COVID-19
7.2 Germany GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
7.2.1 Germany GI tract (Upper and Lower) Market Under COVID-19
7.3 UK GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
7.3.1 UK GI tract (Upper and Lower) Market Under COVID-19
7.4 France GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
7.4.1 France GI tract (Upper and Lower) Market Under COVID-19
7.5 Italy GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
7.5.1 Italy GI tract (Upper and Lower) Market Under COVID-19
7.6 Spain GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
7.6.1 Spain GI tract (Upper and Lower) Market Under COVID-19
7.7 Russia GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
7.7.1 Russia GI tract (Upper and Lower) Market Under COVID-19

8 Asia-Pacific GI tract (Upper and Lower) Market Analysis by Countries
8.1 Asia-Pacific GI tract (Upper and Lower) Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific GI tract (Upper and Lower) Sales by Countries (2015-2020)
8.1.2 Asia-Pacific GI tract (Upper and Lower) Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific GI tract (Upper and Lower) Market Under COVID-19
8.2 China GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
8.2.1 China GI tract (Upper and Lower) Market Under COVID-19
8.3 Japan GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
8.3.1 Japan GI tract (Upper and Lower) Market Under COVID-19
8.4 South Korea GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
8.4.1 South Korea GI tract (Upper and Lower) Market Under COVID-19
8.5 Australia GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
8.6 India GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
8.6.1 India GI tract (Upper and Lower) Market Under COVID-19
8.7 Southeast Asia GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia GI tract (Upper and Lower) Market Under COVID-19

9 Middle East and Africa GI tract (Upper and Lower) Market Analysis by Countries
9.1 Middle East and Africa GI tract (Upper and Lower) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa GI tract (Upper and Lower) Sales by Countries (2015-2020)
9.1.2 Middle East and Africa GI tract (Upper and Lower) Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa GI tract (Upper and Lower) Market Under COVID-19
9.2 Saudi Arabia GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
9.3 UAE GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
9.4 Egypt GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
9.5 Nigeria GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
9.6 South Africa GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)

10 South America GI tract (Upper and Lower) Market Analysis by Countries
10.1 South America GI tract (Upper and Lower) Sales, Revenue and Market Share by Countries
10.1.1 South America GI tract (Upper and Lower) Sales by Countries (2015-2020)
10.1.2 South America GI tract (Upper and Lower) Revenue by Countries (2015-2020)
10.1.3 South America GI tract (Upper and Lower) Market Under COVID-19
10.2 Brazil GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
10.2.1 Brazil GI tract (Upper and Lower) Market Under COVID-19
10.3 Argentina GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
10.4 Columbia GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)
10.5 Chile GI tract (Upper and Lower) Sales and Growth Rate (2015-2020)

11 Global GI tract (Upper and Lower) Market Segment by Types
11.1 Global GI tract (Upper and Lower) Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global GI tract (Upper and Lower) Sales and Market Share by Types (2015-2020)
11.1.2 Global GI tract (Upper and Lower) Revenue and Market Share by Types (2015-2020)
11.2 Antacids Sales and Price (2015-2020)
11.3 Laxatives Sales and Price (2015-2020)
11.4 Antidiarrheal agents Sales and Price (2015-2020)
11.5 Antiemetics Sales and Price (2015-2020)
11.6 Antiulcer agents Sales and Price (2015-2020)
11.7 Other Drug Types Sales and Price (2015-2020)

12 Global GI tract (Upper and Lower) Market Segment by Applications
12.1 Global GI tract (Upper and Lower) Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global GI tract (Upper and Lower) Sales and Market Share by Applications (2015-2020)
12.1.2 Global GI tract (Upper and Lower) Revenue and Market Share by Applications (2015-2020)
12.2 Inflammatory Ulcerative Colitis Sales, Revenue and Growth Rate (2015-2020)
12.3 Cyclic vomiting syndrome (CVS) Sales, Revenue and Growth Rate (2015-2020)
12.4 Dyspepsia Sales, Revenue and Growth Rate (2015-2020)
12.5 Dysphagia Sales, Revenue and Growth Rate (2015-2020)
12.6 Gastroesophageal reflux disease (GERD) Sales, Revenue and Growth Rate (2015-2020)
12.7 Irritable Bowel Syndrome Sales, Revenue and Growth Rate (2015-2020)
12.8 Crohn's Disease Sales, Revenue and Growth Rate (2015-2020)
12.9 Celiac Disease Sales, Revenue and Growth Rate (2015-2020)
12.10 Gastroenteritis Sales, Revenue and Growth Rate (2015-2020)
12.11 Other Applications Sales, Revenue and Growth Rate (2015-2020)

13 GI tract (Upper and Lower) Market Forecast by Regions (2020-2026)
13.1 Global GI tract (Upper and Lower) Sales, Revenue and Growth Rate (2020-2026)
13.2 GI tract (Upper and Lower) Market Forecast by Regions (2020-2026)
13.2.1 North America GI tract (Upper and Lower) Market Forecast (2020-2026)
13.2.2 Europe GI tract (Upper and Lower) Market Forecast (2020-2026)
13.2.3 Asia-Pacific GI tract (Upper and Lower) Market Forecast (2020-2026)
13.2.4 Middle East and Africa GI tract (Upper and Lower) Market Forecast (2020-2026)
13.2.5 South America GI tract (Upper and Lower) Market Forecast (2020-2026)
13.3 GI tract (Upper and Lower) Market Forecast by Types (2020-2026)
13.4 GI tract (Upper and Lower) Market Forecast by Applications (2020-2026)
13.5 GI tract (Upper and Lower) Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source